Native Chip Protocol
Native Chip Protocol - Related Videos
09:46
Capturing Common Fragile Site Breaks by Native γH2A.X ChIP
0 Views •
2025
We present a rapid and efficient method to detect common fragile site breaks through native γH2A.X chromatin immunoprecipitation (ChIP). This approach significantly reduces both the time and labor associated with traditional γH2A.X ChIP assays while maintaining high reproducibility and reliability of results.
12:47
Chromatin Immunoprecipitation (ChIP) Protocol for Low-abundance Embryonic Samples
0 Views •
Cited by 5 •
2017
Here, we describe a chromatin immunoprecipitation (ChIP) and ChIP-seq library preparation protocol to generate global epigenomic profiles from low-abundance chicken embryonic samples.
10:05
Generation of Native Chromatin Immunoprecipitation Sequencing Libraries for Nucleosome Density Analysis
0 Views •
Cited by 12 •
2017
We present a modified native chromatin immunoprecipitation sequencing (ChIP-seq) methodology for the generation of sequence datasets suitable for a nucleosome density ChIP-seq analytical framework integrating micrococcal nuclease (MNase) accessibility with histone modification measurements.
05:48
Rapid Generation of Amyloid from Native Proteins In vitro
0 Views •
Cited by 10 •
2013
Proteins can either adopt a native structure or misfold into insoluble amyloid. Conditions that favor the misfolding pathway lead to the formation of different types of amyloid fibrils. The methods described here allow rapid conversion of native proteins into amyloid in vitro.
01:35
Organ-on-Chip Models
0 Views •
2026
Introduction to Organ-on-Chip Models Organ-on-chip models are advanced microphysiological systems that recreate key structural and functional features of human organs in a controlled laboratory setting. These devices integrate living human cells within microfluidic channels, allowing researchers to simulate tissue–tissue interfaces, fluid flow, and mechanical forces that are essential for normal organ function. Unlike traditional cell cultures, which often lack these dynamic physiological cues,...
FAQs
The nuclease digestion step controls how chromatin is released for immunoprecipitation. Cells or tissues are lysed first, then chromatin is digested under controlled conditions so fragments become available without abandoning the native organization being studied. Because digestion quality affects recovery of these complexes, it is a central source of consistency in occupancy profiles.
Native ChIP Protocol retains non-crosslinked protein-DNA interactions rather than relying on chemically stabilized complexes. This feature can make the measured occupancy profile more biologically relevant to the state present during sample preparation. It also means that preserving chromatin structure during lysis and digestion is especially important, because the assay depends on interactions remaining intact for antibody capture.
Antibody choice determines which chromatin-associated target is enriched. A suitable antibody selectively captures complexes containing the desired histone modification or chromatin-binding protein after digestion, while poor selection can undermine reliable interpretation. For this reason, antibody selection is not merely a reagent choice; it directly determines whether the recovered DNA reflects genomic sites occupied by the intended target.
A basic workflow begins with cells or tissues, followed by lysis under conditions that maintain chromatin structure. Controlled nuclease digestion then releases chromatin fragments, and an antibody captures the target protein-DNA complexes. The captured material is purified before DNA analysis, allowing the experiment to connect a selected chromatin component with its associated genomic regions.
Native ChIP identifies genomic regions associated with selected histone modifications or chromatin-binding proteins. Those occupancy profiles can be used to investigate epigenetic regulation, gene expression, and chromatin organization, making the method useful when the biological question concerns where a chromatin feature or regulatory factor is positioned in the genome.
Digestion must release chromatin fragments while the antibody must selectively recover the intended complexes. A failure in either step can affect the DNA population taken forward for analysis, making it difficult to distinguish biological occupancy from technical variation. Reliable Native ChIP therefore depends on controlling both chromatin processing and target recognition.